STOCKS TELEGRAPH

Tag: QSI

  • Quantum-Si (QSI) Stock Aims To Become a Game-Changer

    Quantum-Si Inc. (NASDAQ: QSI) is a small life sciences company, but one that is making tremendous strides in the elusive domain of protein sequencing. QSI stock is attractive given the company’s remarkable progress and strong financial position.

    Quantum-Si’s Pioneering Role in Protein Sequencing

    A core strength of Quantum-Si Inc. (QSI) comes from its expertise in the emerging yet dynamic field of protein sequencing. The progress the company has made within this domain has been nothing short of remarkable, given that its developed systems are capable of recognizing 15 of 20 amino acids, which allows it to identify 90% of the 20,000 protein forms in the human body. This competitive edge continues to widen, considering Quantum-Si’s growing intellectual property portfolio which consists of over 1000 issued and pending patents. This small life sciences company is on its way to becoming a pioneer by establishing a digital next-gen protein sequencing system.

    Positive QSI financials

    In addition to its promising next-gen protein sequencing capabilities, QSI also has financials that are attractive to its shareholders. In its most recent quarter, the company holds $401 million in cash as per its balance sheet, which gives it a tremendous cash runway, allowing its operations to sustain until the close of 2024. Furthermore, given its decrease in operating costs, the company’s quarterly net loss in June 2022, was down to $32.4 million from the prior year’s comparable of $35.7 million. Although its net loss figures are likely to continue throughout the upcoming quarters, QSI stands in a solid position, giving it the room to innovatively develop its protein sequencing system which is likely to change the dynamics of life sciences, and other areas.

    Conclusion

    QSI stock is attractive due to what it offers, and the potential game-changer it aims to deliver. What is particularly remarkable is its present financial position which allows it to push through with these ambitious for more than two years.

  • Business Updates: Quantum-Si Inc. (QSI) stock Picks Up After Hours

    Business Updates: Quantum-Si Inc. (QSI) stock Picks Up After Hours

    On January 10, Quantum-Si Inc. (QSI) highlighted the business updates that it will present at the 40th Annual J.P. Morgan Healthcare Conference. Consequent to the announcement, the stock picked up after hours to gain 6.31%.

    In the regular trading session, QSI stock suffered a loss of 9.51% at its close of $5.86 with 1.53 million shares exchanging. Following the news, the stock reached $6.23 at an after-hours volume of 34.79K shares.

    The proteomics protein sequencing platform developer, Quantum-Si Inc. was founded in 2013. Currently, its 117.48 million outstanding shares trade at a market capitalization of $886.33 million.

    QSI’s Upcoming Business Updates Presentation

    As per Monday’s announcement, the company will be presenting at the 40th Annual J.P. Morgan Healthcare Conference. Moreover, QSI will be providing its business updates in the presentation. These updates include commercial and technology updates, along with an insight into the 2022 strategic focus.

    Commercial Updates

    The company has concluded its end-to-end protein sequencing platform prices. According to this, i) the PlatinumTM Single-Molecule Analyzer is for $70,000; and ii) CarbonTM automated sample preparation instrument is for $20,000.

    In addition, QSI expects to take pre-order in the first half of 2022 for delivery at full commercial release.

    Technology Updates

    The company has published its first technical manuscript, “Real-time dynamic single-molecule protein sequencing on an integrated semiconductor device” on BioRxiv.

    Further, QSI will also provide updates on its progress with External Early Access Partners.

    2022 Strategic Focus

    On June 10, 2021, the company completed its business combination with HighCape Capital Acquisition Corp. Since then QSI has accomplished various tasks including the successful launch of the early access program, strengthening of the management team and board of directors. Moreover, the company has also expanded its infrastructure for supporting commercialization and growth in the upcoming years.

    Q3 Financial Analysis

    The company declared its financial results for the third quarter ended September 30, 2021, on November 10.

    In the third quarter of 2021, QSI had operating expenses of $25.2 million against $8.6 million in the year-ago quarter. This shows a huge increase of 194% year over year.

    Furthermore, QSI suffered from a net loss of $18.1 million in the third quarter of 2021, against $8.6 million in the year-ago period.

    In addition, the company ended the third quarter of 2021, with cash, cash equivalents, and marketable securities of $500.2 million on September 20, 2021.